CN115536589A - Imidazole ketoxime ester compound, preparation method, composition and application - Google Patents

Imidazole ketoxime ester compound, preparation method, composition and application Download PDF

Info

Publication number
CN115536589A
CN115536589A CN202211366780.2A CN202211366780A CN115536589A CN 115536589 A CN115536589 A CN 115536589A CN 202211366780 A CN202211366780 A CN 202211366780A CN 115536589 A CN115536589 A CN 115536589A
Authority
CN
China
Prior art keywords
group
carbons
alkenyl
alkyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202211366780.2A
Other languages
Chinese (zh)
Inventor
胡汉民
曾裕峰
姜方园
张兴林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Yushida New Material Technology Co ltd
Original Assignee
Jiangsu Yushida New Material Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Yushida New Material Technology Co ltd filed Critical Jiangsu Yushida New Material Technology Co ltd
Priority to CN202211366780.2A priority Critical patent/CN115536589A/en
Publication of CN115536589A publication Critical patent/CN115536589A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00Processes of polymerisation
    • C08F2/46Polymerisation initiated by wave energy or particle radiation
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00Processes of polymerisation
    • C08F2/46Polymerisation initiated by wave energy or particle radiation
    • C08F2/48Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00Processes of polymerisation
    • C08F2/46Polymerisation initiated by wave energy or particle radiation
    • C08F2/48Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light
    • C08F2/50Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light with sensitising agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F222/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
    • C08F222/10Esters
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to novel imidazolone oxime ester compounds, methods of preparation, compositions and uses in photoinitiators, photosensitizers, light absorbers, or photosensitizers. The imidazolone oxime ester compound simultaneously has the structural characteristics of an imidazole photoinitiator (such as BCIM) and a ketoxime ester photoinitiator (such as 0 XE-1). On the one hand, the compounds of the invention improve the disadvantage of sludge formation in imidazole photoinitiators. On the other hand, the compound improves the problem of poor thermal stability of ketoxime ester photoinitiators and increases the convenience of operation.

Description

Imidazole ketoxime ester compound, preparation method, composition and application
Technical Field
The invention relates to novel imidazolone oxime ester compounds, and synthesis and application thereof in photoinitiation or light absorption. The Imidazole ketoxime ester compound has the structural characteristics of functional groups of Imidazole photoinitiators (such as BCIM) and ketoxime ester photoinitiators (such as OXE-1). The compound or composition of the present invention, which is used in the photocuring, optical or electronic industries.
Background
Photoinitiators are important chemicals in the photocuring industry, such as in the fields of coatings, inks, adhesives, photoresists, and the like. The light curing material monomer can activate the unsaturated groups in the light curing material to perform polymerization reaction under the irradiation of a light source with a certain wavelength by adding a photoinitiator, and the light curing material is cured. Good photoinitiators are key to the success of photocuring techniques. Traditional photoinitiators include benzoins, acetophenones, benzophenones, thioxanthones, acylphosphine oxides, aromatic diazo salts, ferrocenes, triazines, hexaarylbisimidazoles, oxime esters, and the like. Of these, the hexaarylbisimidazoles and oxime esters are of particular interest. However, since most of these conventional photoinitiators have disadvantages, their use is greatly limited.
For example, the most representative compound of the hexaaryldiimidazoles, 2,2' -bis (2-chlorophenyl) -4,4',5,5' -tetraphenyl 1,2-diimidazole (BCIM), is generally sensitive to ultraviolet light of shorter wavelength (UVmax: 255 to 275 nm). In practical applications, the BCIM of the two-unit body must be used with a sensitizer or/and a hydrogen donor to achieve better effect (US 4622286, US4162162, US 4459394). Further, BCIM causes a residue accumulation which generates sludge (sludge) in the developer solution during the process of producing printed circuits, and the accumulation of sludge shortens the lifetime of the developer, which is a serious problem. In addition, the novel ketoxime ester photoinitiators, such as typical photoinitiator OXE-1 (CN 99108598 and CN 02811675), can be applied to the manufacture of components of large-screen LCD displays, but have the problems of low melting point (42 ℃) and poor thermal stability, and are unfavorable for transportation and operation.
In view of the above, development of a photoinitiator having high stability, good workability, low sludge, high sensitivity, and reduced use of a sensitizer and/or a hydrogen donor has been the main problem in the industry related to photocuring.
The imidazolone oxime ester compounds of the present invention have never been found to have photoinitiating properties or other optical applications. Imidazolone oxime esters have been found to have pesticidal use (WO 2005108374). Nitro-substituted 2,4,5-triphenyl-benzoyloxy-imidazole oxime compounds were synthesized as CASPLUS (AN 1971, dn 74 125561. A2-methyl-substituted pyridinylacryloyl imidazole compound has been synthesized as CASPLUS (AN 1972. The application is a reaction monomer of polypropylene-styrene (CAS RN 38779-88-3). None of the above compounds disclose photoinitiating properties or other optical applications and all are excluded from the compound claims. CASRN:1674371-29-9, a compound of formula (III) of the present invention, recorded in the CAS Client Services/Source of Registration) of the STN CAS registry database. CASRN:1674371-29-9 is registered by the applicant of the present invention and never leaks any manufacturing or use data. Therefore, the novelty and the creativity of the present invention are not affected at all.
Disclosure of Invention
The imidazolone oxime ester compound simultaneously has the structural characteristics of imidazole photoinitiator (such as BCIM) and ketoxime ester photoinitiator (such as OXE-1) functional groups. On one hand, the imidazole ketoxime ester compound improves the problem of poor thermal stability of a general ketoxime ester (OXE-1) photoinitiator, and increases the operation convenience. On the other hand, the imidazolone oxime ester compounds of the present invention improve the sludge-bearing disadvantage of BCIM photoinitiators. The compound of the present invention has high stability, good workability, low sludge and high maintenance sensitivity. The amount of sensitizer and/or hydrogen donor used can also be reduced.
The structure of the imidazolone oxime ester compound or the salt thereof is shown as the formula (I):
Figure BDA0003920749990000031
wherein R is 1 ~R 4 Is one or more and is each independently selected from the group consisting of hydrogen, hydroxyl, oxy, thio, halogen, amino, nitro, nitroso, cyano, carboxyl, unsubstituted or substituted straight or branched alkyl of 1 to 20 carbons, alkenyl, alkynyl, aryl, heterocyclyl, carbonyl, acyl, alkylamino, alkoxy, alkylthio, arylalkyl, heterocyclylalkyl, arylalkenyl, heterocyclylalkenyl. Wherein oxy or thio means any group attached to the imidazole or ketoxime ester via oxygen or sulfur. Preferably, R 1 Is unsubstituted or substituted straight or branched chain alkyl, alkenyl, carbonyl, aryl, heterocyclyl, arylalkyl, heterocyclylalkyl, arylalkenyl, heterocyclylalkenyl, alkylamino, alkoxy, alkylacyl, arylacyl or heterocyclylacyl containing 1 to 20 carbons; r is 2 ~R 4 Is one or more and is each independently selected from hydrogen, hydroxyl, thio, halogen, amino, nitro, nitroso, cyano, carboxyl, sulfonic, sulfuric, phosphoric, phosphonic, the same or different unsubstituted or substituted straight or branched alkyl groups containing 1 to 20 carbons, alkenyl, aryl, heterocyclyl, arylalkyl, heterocyclylalkyl, arylalkenyl, or heterocyclylalkenyl; r 1 ~R 4 Is one or more and is each independently selected from the group consisting of hydroxy, halogen, amino, nitro, nitroso, cyano, carboxy, sulfo, sulfato, phospho, phosphono, unsubstituted or substituted phenyl, morpholino, benzoyl, unsubstituted or substituted straight or branched C 1 ~C 10 Alkyl radical, C 1 ~C 10 Alkenyl radical, C 1 ~C 10 Acyl radical, C 1 ~C 10 Carbonyl group, OR 5 、SR 5 、SO 2 R 5 、SO 3 R 5 、COOR 5 、COR 5 、OCOR 5 、C(O)NR 6 R 7 、SO 2 NR 6 R 7 Or NR 6 R 7 Wherein R is 5 、R 6 、R 7 Independently of one another, hydrogen, phenyl, straight-chain or branched C 1 ~C 6 Alkyl of (C) 1 ~C 6 Alkenyl or C 1 ~C 6 Alkoxy group of (2). More preferably, R 1 Is unsubstituted or substituted C1-C12 straight or branched chain alkyl, alkenyl, carbonyl, phenyl, biphenyl, alkoxy, alkylamino, alkanoyl, phenylacyl, or biphenylacyl; r 2 、R 3 Is the same or different unsubstituted or substituted aryl group containing 1 to 12 carbons; r 4 Is an unsubstituted or substituted aryl group of 1 to 12 carbons. R 1 -R 4 Is one or more and is each independently selected from the group consisting of hydroxy, halogen, amino, nitro, nitroso, cyano, carboxy, sulfo, sulfato, phospho, phosphono, unsubstituted or substituted phenyl, morpholinyl, benzoyl, unsubstituted or substituted straight or branched C 1 ~C 6 Alkyl radical, C 1 ~C 6 Alkenyl radical, C 1 ~C 6 Acyl radical, C 1 ~C 6 Carbonyl group, OR 5 、SR 5 、SO 2 R 5 SO 3 R 5 、COOR 5 、COR 5 、OCOR 5 、C(O)NR 6 R 7 、SO 2 NR 6 R 7 Or NR 6 R 7 Wherein R is 5 、R 6 、R 7 Independently of one another, hydrogen, phenyl, straight-chain or branched C 1 ~C 6 Alkyl of (C) 1 ~C 6 Alkenyl or C 1 ~C 6 Alkoxy group of (2). Particularly preferably, R 1 Is unsubstituted or substituted C 1~6 Alkyl radical, C 1~6 Alkenyl, phenyl, phenylalkyl, phenylalkenyl, C 1~4 Alkyl acyl, phenyl acyl; r 2~4 Is phenyl; r 1 -R 4 The substituent is hydroxyl, halogen, amino, nitro, cyano, carboxyl, sulfonic group, sulfuric acid group, C 1~6 Alkyl radical, C 1~6 Alkenyl radical, C 1~6 Alkylamino radical, or C 1~6 An alkoxy group. Particularly preferably, R 1 Is C 1 ~C 6 Alkyl of (C) 1 ~C 6 The substituents of which are one or more and are each independently selected from the group consisting of hydroxy, halogen, amino, nitro, nitroso, cyano, sulfonic, sulfuric, phosphoric, phosphonic, carbonyl of 1-6 carbons, ester, acyl, carboxy, alkylamino, alkoxy; r 4 Is phenyl, R 4 The substituents being one or more halogens, or/and C 1 ~C 12 Alkenyl, or/and C 1 ~C 4 Alkoxy, or/and C 1 ~C 12 Alkylamino radical, or/and C 1 ~C 12 Alkyl, wherein the substituents of the alkenyl group are one or more and each is independently selected from the group consisting of hydroxyl, halogen, amino, nitro, nitroso, cyano, sulfonic, sulfuric, phosphoric, phosphonic, carbonyl of 1-6 carbons, ester, acyl, carboxyl, alkylamino, alkoxy, alkyl, alkenyl. Or, R 4 The substituents being one or more halogens, or/and C 1 ~C 6 Alkenyl, or/and C 1 ~C 6 Alkoxy, or/and C 1 ~C 6 Alkylamino radical, or/and C 1 ~C 6 Alkyl, wherein the substituents of the alkenyl group are one or more and each is independently selected from the group consisting of hydroxy, halogen, amino, nitro, nitroso, cyano, carboxy, phosphate, phosphonate, sulfonate, sulfate, C 1~6 Carbonyl group, C 1~6 Ester group, C 1~6 Acyl radical, C 1~6 Alkylamino radical, C 1~6 Alkoxy radical, C 1~6 Alkyl radical, C 1~6 An alkenyl group. Or, R 4 The substituents being one or more halogens, or/and C 1 ~C 4 Alkenyl, or/and C 1 ~C 4 Alkoxy, or/and C 1 ~C 4 Alkylamino radical, or/and C 1 ~C 4 Alkyl, wherein the substituents of the alkenyl group are one or more and each is independently selected from the group consisting of hydroxy, halogen, amino, nitro, nitroso, cyano, carboxy, phosphate, phosphonate, sulfonate, sulfate, C 1~4 Carbonyl group, C 1~4 Ester group, C 1~4 Acyl radical, C 1~4 Alkylamino radical, C 1~4 Alkoxy radical, C 1~4 Alkyl radical, C 1~4 An alkenyl group.
The invention is a compound of formula (II),
Figure BDA0003920749990000051
R 1 is one or more and is each independently selected from unsubstituted or substituted straight or branched chain alkyl, alkenyl, carbonyl, aryl, biphenyl, heterocyclyl, arylalkyl, heterocyclylalkyl, arylalkenyl, heterocyclylalkenyl, alkylamino, alkoxy, alkanoyl, arylacyl or heterocyclylacyl of 1 to 20 carbons; r 4 Each independently selected from unsubstituted or substituted C1-C20 linear or branched alkyl, alkenyl, aryl, heterocyclyl, arylalkyl, heterocyclylalkyl, arylalkenyl, or heterocyclylalkenyl, 4 but R is not nitrobenzene;R 8 Is one or more and is each independently selected from the group consisting of hydrogen, hydroxy, halogen, amino, nitro, nitroso, cyano, carboxy, sulfonic, sulfuric, phosphoric, phosphonic, unsubstituted or substituted phenyl, morpholinyl, benzoyl, unsubstituted or substituted straight or branched C 1 ~C 10 Alkyl radical, C 1 ~C 10 Alkenyl radical, C 1 ~C 10 Acyl radical, C 1 ~C 10 Carbonyl group, OR 5 、SR 5 、SO 2 R 5 、SO 3 R 5 、COOR 5 、COR 5 、OCOR 5 、C(O)NR 6 R 7 、SO 2 NR 6 R 7 Or NR 6 R 7 Wherein R is 5 、R 6 、R 7 Independently of one another, hydrogen, phenyl, straight-chain or branched C 1 ~C 6 Alkyl of (C) 1 ~C 6 Alkenyl or C of 1 ~C 6 Alkoxy group of (2).
Preferably, R 1 Is unsubstituted or substituted C1-C17 straight or branched chain alkyl, alkenyl, carbonyl, aryl, biphenyl, alkoxy, alkylamino, alkanoyl, phenylacyl, biphenylacyl, arylalkenyl; r 4 Of 1 to 12 carbonsUnsubstituted or substituted aryl. R 1 And R 4 Is one or more and is each independently selected from the group consisting of hydroxy, halogen, amino, nitroso, cyano, carboxy, sulfonic, sulfuric, phosphoric, phosphonic, unsubstituted or substituted phenyl, morpholinyl, benzoyl, unsubstituted or substituted straight or branched C 1 ~C 10 Alkyl radical, C 1 ~C 10 Alkenyl radical, C 1 ~C 10 Acyl radical, C 1 ~C 10 Carbonyl group, OR 5 、SR 5 、SO 2 R 5 、SO 3 R 5 、COOR 5 、COR 5 、OCOR 5 、C(O)NR 6 R 7 、SO 2 NR 6 R 7 Or NR 6 R 7 Wherein R is 5 、R 6 、R 7 Independently of one another, hydrogen, phenyl, straight-chain or branched C 1 ~C 6 Alkyl of (C) 1 ~C 6 Alkenyl or C 1 ~C 6 Alkoxy group of (2). More preferably, R is 1 Is unsubstituted or substituted C1-C12 straight or branched chain alkyl, alkenyl, phenylalkenyl, heterocycloalkenyl, carbonyl, phenyl, biphenyl, alkoxy, alkylamino, alkanoyl, phenylacyl, biphenylacyl; r 4 Is an unsubstituted or substituted aryl group of 1 to 12 carbons. R 1 And R 4 Is one or more and is each independently selected from the group consisting of hydroxy, halogen, amino, nitroso, cyano, carboxy, sulfonic, sulfuric, phosphoric, phosphonic, unsubstituted or substituted phenyl, morpholinyl, benzoyl, unsubstituted or substituted straight or branched C 1 ~C 10 Alkyl radical, C 1 ~C 10 Alkenyl radical, C 1 ~C 10 Acyl radical, C 1 ~C 10 Carbonyl group, OR 5 、SR 5 、SO 2 R 5 、SO 3 R 5 、COOR 5 、COR 5 、OCOR 5 、C(O)NR 6 R 7 、SO 2 NR 6 R 7 Or NR 6 R 7 Wherein R is 5 、R 6 、R 7 Independently of one another, hydrogen, phenyl, or naphthylChain or branch C 1 ~C 6 Alkyl of (C) 1 ~C 6 Alkenyl or C 1 ~C 6 Alkoxy group of (2). Particularly preferably, R 1 Is unsubstituted or substituted C 1~6 Alkyl radical, C 1~6 Alkenyl, phenyl, phenylalkyl, phenylalkenyl, C 1~4 Alkanoyl, phenylacyl; r 2~4 Is unsubstituted or substituted phenyl; r 1 And R 4 The substituent is hydroxyl, halogen, amino, nitro, cyano, carboxyl, sulfonic group, sulfuric acid group, C 1~6 Alkyl radical, C 1~6 Alkenyl radical, C 1~6 Alkylamino radical, or C 1~6 An alkoxy group; r 2~4 Is phenyl, R 4 The substituents being one or more halogens, or/and C 1 ~C 12 Alkenyl, or/and C 1 ~C 4 Alkoxy, or/and C 1 ~C 12 Alkylamino radical, or/and C 1 ~C 12 Alkyl, wherein the substituents of the alkenyl group are one or more and each is independently selected from the group consisting of hydroxyl, halogen, amino, nitro, nitroso, cyano, sulfonic, sulfuric, phosphoric, phosphonic, carbonyl of 1-6 carbons, ester, acyl, carboxyl, alkylamino, alkoxy, alkyl, alkenyl. Or, R 4 The substituents being one or more halogens, or/and C 1 ~C 6 Alkenyl, or/and C 1 ~C 6 Alkoxy, or/and C 1 ~C 6 Alkylamino radical, or/and C 1 ~C 6 Alkyl, wherein the substituents of the alkenyl group are one or more and each is independently selected from the group consisting of hydroxy, halogen, amino, nitro, nitroso, cyano, carboxy, phosphate, phosphonate, sulfonate, sulfate, C 1~6 Carbonyl group, C 1~6 Ester group, C 1~6 Acyl radical, C 1~6 Alkylamino radical, C 1~6 Alkoxy radical, C 1~6 Alkyl radical, C 1~6 An alkenyl group. Or, R 4 The substituents being one or more halogens, or/and C 1 ~C 4 Alkenyl, or/and C 1 ~C 4 Alkoxy, or/and C 1 ~C 4 Alkylamino radical, or/and C 1 ~C 4 Alkyl, wherein the substituents of the alkenyl are one or moreAnd each independently selected from hydroxy, halogen, amino, nitro, nitroso, cyano, carboxyl, phosphate, phosphonate, sulfonate, sulfate, C 1~4 Carbonyl group, C 1~4 Ester group, C 1~4 Acyl radical, C 1~4 Alkylamino radical, C 1~4 Alkoxy radical, C 1~4 Alkyl radical, C 1~4 An alkenyl group.
Compounds of importance in the examples of the present invention are compounds of formula (III), (IV), (V), (VI) or (VII):
Figure BDA0003920749990000071
Figure BDA0003920749990000081
the invention also relates to a preparation method of the imidazolone oxime ester compound shown as the formula (I), which is characterized by comprising the following reaction formula:
Figure BDA0003920749990000082
wherein R is 1 ~R 4 Is one or more and is each independently selected from the group consisting of hydrogen, hydroxyl, oxy, thio, halogen, amino, nitro, nitroso, cyano, carboxyl, unsubstituted or substituted straight or branched alkyl of 1 to 20 carbons, alkenyl, alkynyl, aryl, heterocyclyl, carbonyl, acyl, alkylamino, alkoxy, alkylthio, arylalkyl, heterocyclylalkyl, arylalkenyl, heterocyclylalkenyl. X is a leaving group. Preferably, X is OR 13 Halogen, or sulfonate. More preferably, R 13 Is C 1 ~C 10 Alkyl, particularly preferably, R 13 Is C 1 ~C 4 Alkyl, most preferably, R 13 Is methyl. Preferably, halogen is chlorine or bromine, more preferably, halogen is chlorine. The detailed synthesis steps are shown in synthesis reactions 1-5.
The invention also relates to a composition comprising at least one compound of formula (I). The compositions may be used as photoinitiating, light absorbing, photosensitizing, or photosensitizing agents. The composition of the present invention may include a hydrogen donor, a photosensitizer, or various stabilizers.
Suitable hydrogen donors of the present invention include, but are not limited to, organic thiols, 2-mercaptobenzoxazoles, 2-mercaptobenzimidazoles, secondary amines, N-phenylglycine, 1,1-dimethyl-3,5-cyclohexanedione, ethers, esters, alcohols, allyl-or benzylic hydrogen-containing compounds, acetals, aldehydes, and amides. The hydrogen donors can be used singly or in combination.
Suitable photosensitizers for use in the present invention include leuco dyes, polycyclic aromatic species, xanthenes, cyanines, thiazines, acridines, anthraquinones, squaric acids, acridones, chloroacridone, N-methylacridone, N-butylacridone, coumarins, thioxanthones, arylaminones, aromatic ring-or heterocycle-substituted amine-based compounds, disubstituted amino benzophenone-based compounds, or p-dialkylamino-substituted aromatic ring-or heterocycles. The above-mentioned photosensitizers may be used singly or in combination of one or more.
In addition, the compounds of the present invention all have typical optical absorption properties, such as in FIG. 2. Can be used as an ultraviolet light absorber without additives such as monomers, particularly as an ultraviolet light absorber in the UVa-2 waveband, and has industrial applicability. Furthermore, the compounds of the present invention may be used in combination with other photoinitiators, as secondary initiators or photosensitizers. For example, BCIM compounds have a maximum absorption wavelength of 255 to 275nm, and the compounds of the present invention have a light absorption band complementary to the maximum absorption wavelength of the BCIM compounds, and therefore, can be used in combination with BCIM.
Drawings
FIG. 1 is an MS spectrum of 2- (2-chlorophenyl) -4,5-diphenyl-1H-imidazole-1-benzoate, a compound of example 3 of this invention;
FIG. 2 is a graph of the UV absorbance of the compound 2- (2-chlorophenyl) -3-p-methoxycinnamate-4,5-diphenylimidazole of example 9 of the present invention.
Detailed Description
Specific embodiments of the present invention will be described below, but the present invention is not limited to these embodiments.
Synthesis mode 1 is a preparation method of the compound (III) of example 3. The starting diphenylethanedione is reacted with hydroxylamine hydrochloride to obtain the BE oxime. And reacting the BE oxime with ammonium acetate and o-chlorobenzaldehyde. The product was then added more benzoyl chloride to obtain 2- (2-chlorophenyl) -4,5-diphenyl-1H-imidazole-1-benzoate (III).
Figure BDA0003920749990000101
Synthesis reaction 2 is a process for preparing the compound (IV) of example 6. First, BE oxime was reacted with ethyl p-cyanoacrylate benzaldehyde, ammonium acetate. After the product was obtained, benzoyl chloride was added to obtain the objective compound (IV).
Figure BDA0003920749990000102
Synthesis reaction 3 is a process for preparing the compound (V) of example 9. First, methoxybenzaldehyde reacts with ethyl acetate to form p-methoxycinnamic acid. Then reacts with thionyl chloride to form p-methoxy cinnamoyl chloride. And then reacting the 2-o-chlorophenyl-3-hydroxy-4,5-diphenyl imidazole with p-methoxy cinnamoyl chloride to obtain the target compound (V).
Figure BDA0003920749990000111
Synthesis reaction 4 is a process for preparing compound (VII) of example 17. First, benzoylformic acid and thionyl chloride are reacted to benzoylformyl chloride. 2- (2-chlorophenyl) -4,5-diphenyl-1H-imidazol-1-ol imidazole oxime was then added to benzoyl chloride (VII).
Figure BDA0003920749990000112
The synthesis reaction 5 is a preparation method of the alkyl and/or phenyl substituted imidazolone oxime ester compound. Firstly, alkyl diketone reacts with benzaldehyde, hydroxylamine hydrochloride and ammonium acetate to obtain imidazole oxime. And then reacting imidazole oxime with acetyl chloride to obtain the imidazolone oxime ester compound. Compounds having the structural features of imidazolone oxime esters, such as those of formula (XVII), can generally have photoinitiation or the like. Thus, various imidazolone oxime esters can be obtained by reacting various alkyldione starting materials with various phenyl aldehydes or alkyl aldehydes, and further reacting with various acid chlorides.
Figure BDA0003920749990000121
The above synthesis reactions 1,2, 3, 4 and 5 are specific embodiments of the present invention, but the present invention is not limited to these embodiments. The reaction starting material is not limited to a phenylenedione or an alkyldione. Various diketones can be used as starting materials, for example Tetrahedron Letters (1997), 38 (1), 7-10, journal of Organic Chemistry (1999), 64 (16), 6102-6105. Then, the imidazole oxime ester photoinitiators with the formulas (I), (II), (III), (IV), (V), (VI) and (VII) are synthesized according to the method of the synthesis reactions 1-5. Furthermore, various triphenyl-benzoyloxy-imidazole compounds are available via the reaction of triphenyl-imidazole with peroxides such as Benzoyl peroxide. For example, a 2- (2-chlorophenyl) -4,5-diphenyl-1H-imidazole-1-benzoate compound can be obtained by reacting a 2- (2-chlorophenyl) -4,5-diphenyl-1H-imidazole compound with a peroxide such as benzoylperoxide, zeitschrifufuerChemie (1971), 11 (2), pp.62-3.
Example 1
2- (hydroxyimino) -1,2-diphenylethan-1-one
Into a 1000ml reaction flask were charged 210g of diphenylethanedione (BE), 500ml of sodium carbonate 132.5g of methanol, and 71.4g of hydroxylamine hydrochloride. Refluxing at 70 deg.C, and refluxing for 4 hr under heat preservation. After the reaction is finished, concentrating under reduced pressure to obtain viscous BE oxime. After recrystallization, the melting point is 82-84 ℃.
Figure BDA0003920749990000122
Example 2
2- (2-chlorophenyl) -4,5-diphenyl-1H-imidazol-1-ol imidazole oxime
A1000 ml one-necked flask was charged with 500g of acetic acid to dissolve 235g of BE oxime. 121g of ammonium acetate and 147.6g of o-chlorobenzaldehyde are added. The temperature is increased for reflux, and the reflux temperature is started to be 120 ℃. Materials are separated out along with the reaction, and the mixture is refluxed, kept warm and sampled for analysis. After the reaction is finished, pouring the mixture into water, heating to about 40 ℃, and stirring to disperse. 30 Washing with water at 40 ℃ gave the imidazole oxime (94%, UV 254 nm). The compound was decomposed at 270 ℃ (DSC).
Figure BDA0003920749990000131
Example 3
2- (2-chlorophenyl) -4,5-diphenyl-1H-imidazole-1-benzoic acid ester
Into a 1000ml four-necked reaction flask were charged 200g of imidazole oxime (XVIII), 500g of dichloroethane, and 65.6g of triethylamine, and 82g of benzoyl chloride was added dropwise. After the benzoyl chloride was added dropwise, the dichloroethane was evaporated to dryness. Obtaining a solid, recrystallizing, cooling, separating out and discharging to obtain a white powder solid (III). Melting point 136-138 deg.C, MS [ M + H ]] + 451.1。
Figure BDA0003920749990000132
Example 4
2- (2-chlorophenyl) -4,5-diphenyl-1H-imidazol-1-yl-4-dimethylamino-benzoate
Following the procedure of example 3, but substituting 4-dimethylaminobenzoyl chloride for benzoyl chloride, 2- (2-chlorophenyl) -5-phenyl-4- (pyridin-2-yl) -1H-imidazol-1-yl-4-dimethylcarbamate (VIII) was obtained. MS [ M + H ]] + 494.2。
Figure BDA0003920749990000141
Example 5
2- (2-chlorophenyl) -4,5-diphenyl-1H-imidazol-1-yl dibenzoate
According to the examplesProcess 3, but replacing the benzoyl chloride with 4-bibenzoyl chloride, gives 2- (2-chlorophenyl) -5-phenyl-4- (pyridin-2-yl) -1H-imidazol-1-yl bibenzoate (IX). MS [ M + H ]] + 527.1。
Figure BDA0003920749990000142
Example 6
2- (4- (2-acetoxy-2-cyanovinyl) -2-chlorophenyl) -4,5-diphenyl-1H-imidazole-1-benzoic acid ester
A500 ml reaction flask was charged with 22.5g of BE oxime, 23g of ethyl p-cyanoacrylate benzaldehyde, 15.4g of ammonium acetate and 200g of acetic acid, and subjected to a reflux reaction for 6 hours. The temperature is reduced to 60 ℃, and solid is filtered out. Washing with methanol, and oven drying. 4.4g of the dried solid is taken and put into a 250ml reaction bottle, 50g of dichloroethane and 2g of triethylamine are added and stirred. A solution of 1.4g of benzoyl chloride in dichloroethane is added dropwise at 15 ℃. After 30 minutes, the mixture is kept warm for one hour. The solid was filtered directly and washed with water to give a yellow solid powder. MS [ M + H ]] + 574.1。
Figure BDA0003920749990000151
Example 7
P-methoxy cinnamic acid
A1000 ml reaction flask was charged with 360 g of toluene, 100 g of anhydrous ethyl acetate, and 40.9 g of sodium methoxide. 68 g of p-methoxybenzaldehyde in ethyl acetate are added dropwise under nitrogen and sampled for analysis. Cooling and acidifying in sulfuric acid water solution. And recovering the solvent. Adding sodium hydroxide into the concentrate, heating for hydrolysis, cooling and neutralizing with dilute sulfuric acid. Filtering, washing with water, washing with methanol, and drying to obtain yellowish p-methoxycinnamic acid powder.
Figure BDA0003920749990000152
Example 8
P-methoxy cinnamoyl chloride
9.8 g of p-methoxycinnamic acid, 20g of dichloroethane and 13.1 g of thionyl chloride were added to a 250ml reaction flask and the mixture was heated to reflux. The reaction was maintained at reflux for 3 hours, and unreacted thionyl chloride and dichloroethane were distilled off.
To obtain the p-methoxy cinnamoyl chloride. The concentrate was dissolved in 40 g of dichloroethane and directly subjected to the next synthesis.
Figure BDA0003920749990000153
Example 9
2- (2-chlorophenyl) -3-p-methoxycinnamate-4,5-diphenylimidazole
After 17.4 g of 2- (2-chlorophenyl) -3-hydroxy-4,5-diphenylimidazole (XVIII), 5.9 g of triethylamine and 120g of dichloroethane were added to a 250ml reaction flask, the newly synthesized p-methoxycinnamoyl chloride was added dropwise. The addition is completed within 1.5 hours, and the dropping temperature is 5-10 ℃. After washing with water, the solvent was recovered. 90 g of methanol are added at 50 Stirring at 60 ℃ for 1 hour, cooling to 10-20 ℃, filtering, and washing with a small amount of methanol to obtain a pale yellow solid (XV), melting point: 161-162 ℃.
Figure BDA0003920749990000161
Example 10
2- (2-chlorophenyl) -4,5-diphenyl-1H-imidazol-1-yl acetate
According to the method of example 3, 200g of dried imidazoloxime (XVIII), 500g of dichloroethane, 65.6g of triethylamine were charged into a 1000ml four-necked reaction flask, and 45.5g of acetyl chloride was added dropwise. To give 2- (2-chlorophenyl) -4,5-diphenyl-1H-imidazol-1-yl acetate (X). MS [ M + H ]] + 389.1。
Figure BDA0003920749990000162
Example 11
2- (2-chlorophenyl) -4,5-diphenyl-1H-imidazol-1-yl stearate
According to the method of example 3, 200g of directly dried imidazole oxime (XVIII), 500g of dichloroethane, 65.6g of triethylamine and 175.1g of stearoyl chloride were charged into a 1000ml four-necked reaction flask. To give 2- (2-chlorophenyl) -4,5-diphenyl-1H-imidazol-1-yl stearate (XI). MS [ M + H ]] + 613.4。
Figure BDA0003920749990000171
Example 12
2- (2-chlorophenyl) -5-phenyl-4- (pyridin-2-yl) -1H-imidazole-1-benzoic acid ester
The procedure of example 3 was followed except that 1-phenyl-2- (pyridin-2-yl) ethane-1,2-dione was used in place of BE ketone.
To obtain 2- (2-chlorphenyl) -5-phenyl-4- (pyridine-2-yl) -1H-imidazole-1-benzoic acid ester (XII).
Figure BDA0003920749990000172
Example 13
2- (2-chlorophenyl) -4,5-bis (4-methoxyphenyl) -1H-imidazole-1-benzoic acid ester
The procedure of example 3 was followed except that 1,2-bis (4-methoxyphenyl) ethane-1,2-dione was used in place of BE ketone.
2- (2-chlorophenyl) -4,5-bis (4-methoxyphenyl) -1H-imidazole-1-benzoic acid ester (XIII) is obtained.
Figure BDA0003920749990000173
Example 14
2- (2-chlorophenyl) -4- (naphthalen-2-yl) -5-phenyl-1H-imidazole-1-benzoic acid ester
The procedure of example 3 was followed, but 1- (naphthalen-2-yl) -2-phenylethane-1,2-dione was used instead of BE ketone. 2- (2-chlorophenyl) -5-phenyl-4- (pyridin-2-yl) -1H-imidazole-1-benzoic acid ester (XIV) is obtained.
Figure BDA0003920749990000181
Example 15
2- (2-chlorophenyl) -4,5-diphenyl-1H-imidazol-1-yl acrylate
According to the method of example 3, 200g of oven-dried imidazole oxime (XVIII), 500g of dichloroethane, 65.6g of triethylamine and 52.2g of acryloyl chloride were charged into a 1000ml four-necked reaction flask. After the acryloyl chloride is dripped off, the dichloroethane is evaporated to dryness. 2- (2-chlorophenyl) -4,5-diphenyl-1H-imidazol-1-yl acrylate (XV) is obtained. MS [ M + H ]] + 401.1。
Figure BDA0003920749990000182
Example 16
2- (2,4-dichlorophenyl) -4,5-diphenyl-1H-imidazole-1-benzoic acid ester
The procedure of example 3 was followed except that o-chlorobenzaldehyde was replaced with 2,4 dichlorobenzaldehyde. 2- (2,4-dichlorophenyl) -4,5-diphenyl-1H-imidazole-1-benzoic acid ester (XVI) is obtained.
Figure BDA0003920749990000183
Example 17
2- (2,4-dichlorophenyl) -4,5-diphenyl-1H-imidazole-1-benzoic acid ester 2-oxo-2-benzoate
120g of benzoylformic acid and 50ml of thionyl chloride were added to a reaction vessel, and the reaction was stirred under reflux. After 2 hours, the mixture was distilled under reduced pressure to obtain benzoyl chloride. Into a 1000ml four-necked reaction flask, 200g of 2- (2-chlorophenyl) -4,5-diphenyl-1H-imidazol-1-ol imidazoxime (XVIII) obtained in example 2, 500g of dichloroethane, 65.6g of triethylamine and 82g of benzoyl chloride were added dropwise. 2- (2,4-dichlorophenyl) -4,5-diphenyl-1H-imidazole-1-benzoic acid ester-2-oxo-2-benzoate (VII) is obtained. MS [ M + H ]] + 479.1。
Figure BDA0003920749990000191
Example 18
2- (4- (2-methylamino) phenyl) -4,5-diphenyl-1H-imidazole-1-benzoic acid ester
Following the procedure of example 3, but substituting 3-chloro-4- (dimethylamino) benzaldehyde for o-chlorobenzaldehyde, 2- (4- (2-methylamino) phenyl) -4,5-diphenyl-1H-imidazole-1-benzoic acid ester was obtained. MS [ M + H ]] + 494.2。
Figure BDA0003920749990000192
Example 19
2- (2-chlorophenyl) -4,5-diphenyl-1H-imidazol-1-yl 2-oxopropanoate
Following the procedure of example 17, but substituting 2-oxopropionyl chloride for benzoylcarbonyl chloride. To give 2- (2-chlorophenyl) -4,5-diphenyl-1H-imidazol-1-yl 2-oxopropanoate. MS [ M + H ]] + 417.1。
Figure BDA0003920749990000201
TABLE 1 Compounds synthesized in examples 3-6,9-19
Figure BDA0003920749990000202
Figure BDA0003920749990000203
Figure BDA0003920749990000211
EXAMPLE 20 comparative operability of the example Compounds with OXE 01 ketoxime ester
IRGACURE OXE 01, chemical name 2- (O-benzoyloxime) -1- [4- (phenylthio) phenyl ] -1,2-octanedione, or the solid compound of examples 3-19, was taken at room temperature and placed in a clear glass container and filled. After 24 hours of standing, the compound was decanted and the container was observed for residue. The residual amount can be expressed directly as the transmittance, or diluted after dissolving in a solvent, and the UV absorption value (UV-VIS spectrophotometry) is measured. Higher transmittance indicates less residual amount. The residual amount represents the handling property. The more residual amount means the worse the operation performance. The residual amounts were classified into the following grades: 0= very small residue, 1= small residue, 2= medium residue, 3= large residue.
TABLE 2 Room temperature operability
Examples 3-19 Compounds IRGACURE OXE 01
Residue is remained 0-1 2
Operability of Jia Not good at
EXAMPLE 21 comparison of the thermal stability of the example Compounds with OXE 01 ketoxime ester
Samples of the compounds of examples 3-19 or the control IRGACURE OXE 01, each 5mg, were taken and compared for thermal stability under a thermogravimetric analyzer (TGA) nitrogen atmosphere. The conditions are that the heating rate is 10 ℃/min, the initial temperature is 25 ℃, and the finishing temperature is 200 ℃. Greater weight loss represents less stability. As a result, the weight loss of the exemplified compound was less than 5% and the weight loss of IRGACURE OXE 01 was greater than 9%.
TABLE 3 thermal stability test results
Figure BDA0003920749990000221
Example 22 sludge (flattest) to sensitization test comparison of example compound to BCIM 3.0% of an example photoinitiating compound or a control compound BCIM (photo 900, eutec co dissolved in tetrahydrofuran), 0.15% of N-phenylglycine hydrogen donor (photo NPG, eutec co), 0.3% of 4,4-bis (N, N' -dimethyl-amino) benzophenone (photo EAB, eutec co), 36.5% of a difunctional acrylate monomer and 60% of an acrylate oligomer were mixed. The above photosensitive composition was coated on a copper sheet or a polyester sheet, dried, and irradiated with a high-pressure UV lamp to perform sludge and photosensitive tests (table 4). The sludge test involves placing the copper sheet in a developer solution and allowing it to stand until the sample dissolves. The developer solution was prepared by dissolving 20g of sodium carbonate in 2 liters of water and adding 1.5ml of a nonionic surfactant of polyoxyethylene/polyoxypropylene copolymer. The precipitation amount was classified by the following scale: 0= no light yellow precipitate, 1= a small amount of finely divided pale yellow, 2= a medium amount of pale yellow, 3= a large solid layer of pale yellow on the bottom. The accumulation of sludge shortens the lifetime of the developer. The more sludge, the worse the result. The film produced above was subjected to dry to touch (dry to touch) to record the number of exposures to achieve good surface hardness. The lower the number of exposures, the better the photosensitivity.
Table 4 sludge test results
Examples 3-19 Compounds Control group BCIM compound
Sludge grade 0-1 2-3
Number of exposures 4-5 5
Example 23 absorption experiments
Example compounds 3-6,9-19 all had typical optical absorption properties, such as the compound of example 7 (fig. 2). The transmittance of BCIM compounds of the examples and the comparative examples is measured by a UV-VIS spectrometer by taking equal amount of acetonitrile as a solvent. It is shown that the compound can be used as an ultraviolet light absorber without additives such as monomers, particularly as an ultraviolet light absorber in the UVa waveband, and has industrial applicability.
The foregoing is only a preferred embodiment of the present invention. It will be apparent to those skilled in the art that various modifications and variations can be made in the present invention without departing from the scope of the invention. Such modifications and variations are considered to be within the scope of the invention.

Claims (2)

1. An application of imidazolone oxime ester compound or salts thereof in a photoinitiator, a photosensitizer, a light absorber or a photosensitizer is characterized in that the structural formula of the imidazolone oxime ester compound is shown as the formula (I):
Figure FDA0003920749980000011
wherein R is 1 Is unsubstituted or substituted, and contains C1-20 straight chain or branched chain alkyl, C1-20 alkenyl, C1-20 carbonyl, C1-20 aryl, C1-20 heterocyclic radical, C1-20 arylalkyl, C1-20 heterocyclic alkyl, C1-20 arylalkenylA heterocyclylalkenyl group of carbons, an alkylamino group of 1-20 carbons, an alkoxy group of 1-20 carbons, an alkanoyl group of 1-20 carbons, an arylacyl group of 1-20 carbons, or a heterocyclylacyl group of 1-20 carbons; r 2 -R 4 Is one or more and is independently selected from hydrogen, hydroxyl, halogen, amino, nitro, cyano, carboxyl, sulfonic acid group, unsubstituted or substituted straight or branched alkyl group having 1 to 12 carbons, alkenyl group having 1 to 12 carbons, aryl group having 1 to 12 carbons, heterocyclic group having 1 to 12 carbons, arylalkyl group having 1 to 12 carbons, heterocyclylalkyl group having 1 to 12 carbons, wherein R is 1 -R 4 Is one or more and is each independently selected from the group consisting of hydroxy, halogen, amino, nitro, cyano, carboxy, sulfo, phenyl, morpholino, benzoyl, straight or branched C 1~ C 10 Alkyl radical, C 1~ C 10 Acyl radical, C 1~ C 10 Carbonyl group, OR 5 、COOR 5 、COR 5 、C(O)NR 6 R 7 Or NR 6 R 7 Wherein R is 5 、R 6 、R 7 Independently of one another, hydrogen, phenyl, straight-chain or branched C 1~ C 6 Alkyl of (C) 1~ C 6 Alkenyl or C 1~ C 6 And unsubstituted or substituted C 1~ C 10 Alkenyl, wherein the substituent of alkenyl is one or more and each is independently selected from hydroxyl, halogen, amino, nitro, cyano, sulfonic acid group, carbonyl group of 1-6 carbons, ester group of 1-6 carbons, acyl group of 1-6 carbons, carboxyl group of 1-6 carbons, alkylamino group of 1-6 carbons, alkoxy group of 1-6 carbons, alkyl group of 1-6 carbons, alkenyl group of 1-6 carbons.
2. Use of the imidazolone oxime ester compound according to claim 1, R 1 Is unsubstituted or substituted C 1~ C 17 Alkyl of (C) 1~ C 6 Is one or more and is independently selected from hydroxyl, halogen, amino, nitro, cyano, sulfonic acid group, carbonyl group of 1-6 carbons, ester group of 1-6 carbons, acyl group of 1-6 carbons, carboxyl group of 1-6 carbonsAlkyl amino with 1-6 carbon atoms and alkoxy with 1-6 carbon atoms; r 4 Is unsubstituted or substituted phenyl, R 4 The substituents being one or more halogens, or/and C 1~ C 4 Alkenyl, or/and C 1~ C 4 Alkoxy, or/and C 1~ C 4 Alkylamino radical, or/and C 1~ C 4 And an alkyl group, wherein the substituent of the alkenyl group is one or more and each is independently selected from the group consisting of a hydroxyl group, a halogen group, an amino group, a nitro group, a cyano group, a sulfonic group, a carbonyl group having 1 to 6 carbons, an ester group having 1 to 6 carbons, an acyl group having 1 to 6 carbons, a carboxyl group having 1 to 6 carbons, an alkylamino group having 1 to 6 carbons, an alkoxy group having 1 to 6 carbons, an alkyl group having 1 to 6 carbons, and an alkenyl group having 1 to 6 carbons.
CN202211366780.2A 2017-10-23 2017-10-23 Imidazole ketoxime ester compound, preparation method, composition and application Pending CN115536589A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202211366780.2A CN115536589A (en) 2017-10-23 2017-10-23 Imidazole ketoxime ester compound, preparation method, composition and application

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202211366780.2A CN115536589A (en) 2017-10-23 2017-10-23 Imidazole ketoxime ester compound, preparation method, composition and application
CN201710993082.8A CN109694352B (en) 2017-10-23 2017-10-23 Imidazole ketoxime ester compound, preparation method, composition and application

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201710993082.8A Division CN109694352B (en) 2017-10-23 2017-10-23 Imidazole ketoxime ester compound, preparation method, composition and application

Publications (1)

Publication Number Publication Date
CN115536589A true CN115536589A (en) 2022-12-30

Family

ID=66225841

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202211366780.2A Pending CN115536589A (en) 2017-10-23 2017-10-23 Imidazole ketoxime ester compound, preparation method, composition and application
CN201710993082.8A Active CN109694352B (en) 2017-10-23 2017-10-23 Imidazole ketoxime ester compound, preparation method, composition and application

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201710993082.8A Active CN109694352B (en) 2017-10-23 2017-10-23 Imidazole ketoxime ester compound, preparation method, composition and application

Country Status (3)

Country Link
CN (2) CN115536589A (en)
TW (1) TW201922712A (en)
WO (1) WO2019080788A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115109028B (en) * 2022-08-29 2023-06-02 安庆师范大学 Oxime ester compound and preparation method and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0239868A1 (en) * 1986-03-20 1987-10-07 BASF Aktiengesellschaft Photochromic system, layer prepared thereof and its use
JP2006225498A (en) * 2005-02-17 2006-08-31 Asahi Kasei Electronics Co Ltd Photopolymerization initiator
CN101525393A (en) * 2009-04-02 2009-09-09 优缔精细化工(苏州)有限公司 Oxime ester photoinitiator and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0239868A1 (en) * 1986-03-20 1987-10-07 BASF Aktiengesellschaft Photochromic system, layer prepared thereof and its use
JP2006225498A (en) * 2005-02-17 2006-08-31 Asahi Kasei Electronics Co Ltd Photopolymerization initiator
CN101525393A (en) * 2009-04-02 2009-09-09 优缔精细化工(苏州)有限公司 Oxime ester photoinitiator and preparation method thereof

Also Published As

Publication number Publication date
TW201922712A (en) 2019-06-16
CN109694352B (en) 2023-04-07
WO2019080788A1 (en) 2019-05-02
CN109694352A (en) 2019-04-30

Similar Documents

Publication Publication Date Title
EP3095778B1 (en) Oxime ester fluorene compound, photopolymerization initiator comprising it, photoresist composition, uses of the photoresist composition
DK173995B1 (en) Use of alpha-hydroxy ketone compounds functionalized with reactive groups as co-reactive photoinitiators, a process for photopolymerization of systems containing ethylenically unsaturated compounds ......
KR100979660B1 (en) Incorporable photoinitiator
US10040810B2 (en) Derivatives of bisacylphosphinic acid, their preparation and use as photoinitiators
JP3798008B2 (en) Oxime ester compound and photopolymerization initiator containing the compound
CA2681201C (en) Photoactivable nitrogen bases
KR101723693B1 (en) Novel oligofunctional photoinitiators
JP6408715B2 (en) Novel oxime ester derivative compound, photopolymerization initiator containing the same, and photoresist composition
DE69839020T2 (en) Photoactivatable nitrogenous bases based on ALPHA ammonium, iminium or amidinium ketones and arylborates
JPH0429681B2 (en)
JPH0816123B2 (en) Photocurable coloring composition
CZ20004636A3 (en) Oxime ester photoinitiators
DE19753655A1 (en) New alpha-aminoacetophenone photo starters
JP6261778B2 (en) Asymmetric dioxime ester compound and its production method and application
CH701054B1 (en) A photoactive compound and a photosensitive resin composition containing this compound.
WO2004104051A1 (en) Bimolecular photoinitiator systems
CN109694352B (en) Imidazole ketoxime ester compound, preparation method, composition and application
CN113444017B (en) Diphenyl-sulfide-ether-ketone oxime ester compound, preparation method, composition and application
JP2004503545A (en) Triazine-based compounds containing functional alkylthio groups and photopolymerization initiators
KR20090107977A (en) Photoactive compound, and photosensitive resin composition comprising the same
Seo et al. Development of radical initiator based on o-imino-isourea capable of photo/thermal polymerization
US20100093883A1 (en) Hydroxamic Esters as Photoinitiators
US20050119432A1 (en) Photo radical generator, photo sensitive resin composition and article

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination